MUC4 and neoplasm: Based on our recent work, we propose miR-219-1-3p as a good tumor-suppressor candidate to inhibit MUC4 expression, MUC4-mediated downstream signaling pathways, and MUC4-independent cellular tumor suppressor mechanisms highlighting the therapeutic potential of this miRNA in pancreatic cancer (Figure 1).